Vir Biotechnology, Inc.VIRNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
55.33%
↑ 461% above average
Average (30q)
9.87%
Historical baseline
Range
High:85.68%
Low:-45.65%
Volatility
1331.0%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 55.33% |
| Q2 2025 | -17.81% |
| Q1 2025 | 11.84% |
| Q4 2024 | -45.65% |
| Q3 2024 | 85.68% |
| Q2 2024 | 4.98% |
| Q1 2024 | -8.11% |
| Q4 2023 | -24.87% |
| Q3 2023 | -13.72% |
| Q2 2023 | 6.62% |
| Q1 2023 | 1.59% |
| Q4 2022 | 35.92% |
| Q3 2022 | -0.80% |
| Q2 2022 | 27.55% |
| Q1 2022 | -29.70% |
| Q4 2021 | 30.07% |
| Q3 2021 | 14.56% |
| Q2 2021 | -36.14% |
| Q1 2021 | 54.85% |
| Q4 2020 | 23.22% |
| Q3 2020 | -11.26% |
| Q2 2020 | 22.58% |
| Q1 2020 | 22.76% |
| Q4 2019 | 32.78% |
| Q3 2019 | 33.75% |
| Q2 2019 | 15.20% |
| Q1 2019 | 17.74% |
| Q4 2018 | -26.36% |
| Q3 2018 | 23.25% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |